At Clarify Clinics, Prof. Antonio Belli serves as a medical advisor, guiding clinical research and patient care protocols while integrating clinical practice, research leadership, and policy advising. He is a global expert in neurotrauma and traumatic brain injury (TBI), with extensive experience in diagnosing, monitoring, and treating neurological injuries. He is a practicing neurosurgeon at the University of Birmingham and Queen Elizabeth Hospital Birmingham and has led major international research programs, including serving as Chief Investigator of RECOS, one of the world’s largest neurotrauma studies.

Prof. Belli also serves as a faculty member at the National Institute for Health Research Senior Investigators, Chair of the World Federation of Neurosurgical Societies Military Committee, and Vice Chair of the European Association of Neurosurgical Societies Neurotrauma and Critical Care Committee. He provides expert guidance to national and international organizations and has contributed to clinical guidelines and education for multiple professional bodies.

David Cohen is the Director, Chairman, and CEO of Marker AG. He brings over 30 years of international experience in identifying, building, listing, and selling global private and public corporations. Throughout his career, David has directly raised more than $1.5 billion in equity and led mergers and acquisitions transactions exceeding $12 billion across diverse industries.

At Clarify Clinics, David applies his strategic vision and business leadership to support the growth and operational scaling of the organization, while fostering innovations that advance patient care and expand access to cutting-edge medical protocols. His long-standing passion for healthcare drives his commitment to enabling Clarify Clinics to deliver meaningful improvements in health outcomes.

Yael Cohen is the Chief Executive Officer of Clarify Clinics, where she directs operations, shapes healthcare strategy, and manages organizational growth. She ensures patients receive forward-thinking, personalized care while advancing innovative programs that optimize healthspan and systemic health. Yael is also the founder of F Cancer, a nonprofit established in 2009 after her mother’s breast cancer diagnosis, which has grown into a global movement focused on early detection, prevention, and patient support. Through innovative campaigns and partnerships, F Cancer has mobilized millions to change how younger generations engage with health and wellness.

Yael has been recognized globally as a leading voice in healthcare advocacy and entrepreneurship, with her work featured in outlets such as Forbes, Fast Company, and The New York Times, and she has spoken at major forums including TED and the United Nations. She brings more than a decade of experience at the intersection of healthcare, advocacy, and innovation, and is committed to shaping a patient-first approach to longevity and subtractive medicine at Clarify Clinics.

Tinus Maree is the Director and General Counsel of Clarify Clinics, where he oversees legal strategy, corporate governance, and compliance. He is a commercial lawyer by training who transitioned to international investment banking and private equity, bringing over 27 years of experience in M&A, corporate finance, and shareholder value creation.

Throughout his career, Tinus has advised on and executed a wide range of complex transactions across public and private capital markets in Europe, Canada, and Africa. At Clarify Clinics, he leverages this expertise to provide robust governance, strategic legal oversight, and risk management, while supporting the clinic’s growth, cross-border operations, and the implementation of innovative healthcare solutions.